InsidersTradesSigma
Explore the complete record of transactions filed by Elston George, Chief Financial Officer. Director active across 1 company, notably EyePoint Pharmaceuticals, Inc.. Aggregated, 2 filings have been recorded. Activity tracked since 9 February 2022. The latest transaction was filed on 9 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
George Elston is the Chief Financial Officer at EyePoint Pharmaceuticals, Inc. He is responsible for financial management and the company's financial strategy. His expertise contributes to the growth and sustainability of the organization.